Review: adam-adex-infusion-duration

[Cassie-Shen]

Review of the adam-adex-infusion-duration benchmark.

Question	Answer
Task: Would you agree that the benchmark use case represents real data derivation in clinical trials?	Agree
Inputs: Would you agree that the inputs and outputs represent real data structures collected in clinical trials?	Agree
AI-assisted review: Would you agree with how this benchmark handles each potential concern below?	Agree
Overall	Approve

Comments

Agree to all of them, I just have one concern: If CALCDUR is only an intermediate variable used to derive AVAL, I would recommend excluding it from the final ADEX dataset. However, if it is needed for analysis or traceability, I would support keeping it.